Regenelead Therapies Co., Ltd., founded in August 2021, is a biotechnology company focused on the development of cell and gene therapies. The company has established an AI-powered comprehensive technical platform of AAV, mRNA, cell therapy, and in vivo CAR-T, along with an automated end-to-end manufacturing process. Our pipeline covers the therapeutic areas with high unmet medical needs including neurology, ophthalmology, oncology, vascular diseases, chronic wounds, etc., aiming to create a healthier life for patients.